Rare incidence of primary adrenocortical carcinosarcoma: A case report and literature review.

Oncol Lett

Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, P.R. China.

Published: January 2015

Adrenocortical carcinoma (ACC) is a rare, but highly aggressive type of tumor with an incidence of one to two per million annually. Adrenocortical carcinosarcoma is an exceptional variant of ACC, which is characterized by the presence of histological regions of carcinoma and sarcoma. To date, to the best of our knowledge, there have only been 12 reported cases of adrenocortical carcinosarcoma. In the present study, a case of primary, non-functional adrenocortical carcinosarcoma is described, as well as a review of the literature to raise awareness of this particularly rare type of malignant neoplasm that is associated with a worse diagnosis and prognosis than adrenocortical carcinoma. In the present study, the patient underwent a laparoscopic left adrenalectomy and the tumor was dissected without complication from the left kidney. Microscopic observations showed the tumor comprised of epithelial and spindle cell components. The patient did not exhibit signs of tumor recurrence at the one-month follow-up. The potential diagnosis of adrenocortical carcinosarcoma must be considered when diagnosing adrenal malignancies in adults. In addition, comphrensive imunohistochemical staining may be required to identify possible sarcomatous patterns. To the best of our knowledge, the present case is the first to report an incidence of adrenocortical carcinosarcoma in China. Details of the patient are presented and the pathology of adrenocortical carcinosarcoma is discussed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247116PMC
http://dx.doi.org/10.3892/ol.2014.2635DOI Listing

Publication Analysis

Top Keywords

adrenocortical carcinosarcoma
28
adrenocortical
9
case report
8
adrenocortical carcinoma
8
best knowledge
8
carcinosarcoma
7
rare incidence
4
incidence primary
4
primary adrenocortical
4
carcinosarcoma case
4

Similar Publications

Article Synopsis
  • Epstein-Barr virus (EBV) infection is linked to various cancers, but the role of EB nuclear antigen 1 binding protein 2 (EBNA1BP2) in tumors is not well understood, prompting an investigation into its potential as a prognostic biomarker across multiple cancer types.
  • Utilizing extensive bioinformatics analyses on data from TCGA and GEO databases, the study assessed EBNA1BP2's expression, prognostic significance, immune infiltration, and methylation levels in pan-cancer.
  • Results indicated that higher EBNA1BP2 expression is seen in tumor tissues, with lower levels correlating to better survival rates in specific cancers; it also plays roles in cell cycle regulation, DNA repair, and immune cell
View Article and Find Full Text PDF

Neuropilin 1 (NRP1/CD304) is a typical membrane-bound co-receptor for vascular endothelial growth factor, semaphorin family members and viral severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, NRP1 expression levels across cancer types and the potential role of SARS-CoV-2 infection in patients with cancer are not clear. Online databases, such as The Cancer Genome Atlas database of Human Protein Atlas, Gene Expression Profiling Interactive Analysis and cBioPortal were used for the expression analysis in this study.

View Article and Find Full Text PDF
Article Synopsis
  • APOBEC type 3C (A3C) is identified as a potential cancer biomarker for lower-grade gliomas (LGGs), but its specific role in improving clinical outcomes through immunotherapy is still unclear.
  • Research utilized RNA sequencing and bioinformatic analyses to find that A3C is expressed significantly higher in LGGs compared to normal tissues, making it an independent predictor for patient prognosis.
  • The study also discovered that A3C is associated with immune cell infiltration and chemotherapy sensitivity, suggesting that targeting A3C could improve immunotherapy effectiveness for LGGs.
View Article and Find Full Text PDF

The BRCAness Landscape of Cancer.

Cells

December 2022

MoE Frontiers Science Center for Precision Oncology, Cancer Centre and Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau 999078, China.

BRCAness refers to the damaged homologous recombination (HR) function due to the defects in HR-involved non- genes. BRCAness is the important marker for the use of synthetic lethal-based PARP inhibitor therapy in breast and ovarian cancer treatment. The success provides an opportunity of applying PARP inhibitor therapy to treat other cancer types with BRCAness features.

View Article and Find Full Text PDF

Purpose: The main function of cartilage oligomeric matrix protein (COMP) is to maintain the synthesis and stability of the extracellular matrix by interacting with collagen. At present, there are relatively few studies on the role of this protein in tumors. This study aimed to explore the relationship between COMP and pan-cancer, and analyzed its diagnostic and prognostic value.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!